glp-1 and mcas Glucagon-like peptide-1 receptor: mechanisms advances in therapy Understanding GLP-1 receptor agonists and

GABA is made from glutamate, an excitatory neurotransmitter, using the GAD1 and GAD2 enzymes with the active form of vitamin B6 (P5P) as a cofactor

It is in the brain that fatigue is perceived, but the location of the interoceptive sensors signalling deviations from a balanced homeostatic state remains unclear

Given the novel nature of this class of drug, there was also heterogeneity in the GLP-1 RM regimen, dosage and administration time between studies

Separate lawsuits involving vision loss, blood clots, and other serious adverse events are moving forward outside the MDL, signaling broader scrutiny of GLP-1 safety warnings and risk disclosures